Last €2.80 EUR
Change Today -0.175 / -5.88%
Volume 0.0
RN3 On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:02 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - arena pharmaceuticals inc (RN3)

Name (Connections)Board RelationshipsTitleKey Developments
Phillip Schneider 21 RelationshipsDirector and Chairman of Audit Committee 
Christine White M.D. 21 RelationshipsLead Independent Director, Member of Compensation Committee, Member of Audit Committee and Member of Science Committee 
Scott Bice 13 RelationshipsIndependent Director, Member of Audit Committee and Member of Corporate Governance & Nominating Committee 

Compensation Committee* - arena pharmaceuticals inc (RN3)

Name (Connections)Board RelationshipsTitle
Tina Nova Bennett Ph.D. 15 RelationshipsDirector, Chairman of Compensation Committee and Member of Science Committee
Christine White M.D. 21 RelationshipsLead Independent Director, Member of Compensation Committee, Member of Audit Committee and Member of Science Committee
Randall Woods 71 RelationshipsIndependent Director and Member of Compensation Committee
RN3 Compensation vs. Industry
725.0K
361.0K
Chief Executive Officer
360.0K
266.6K
Chief Financial Officer
Share price activity for ARENA PHARMACEUTICALS INC (RN3)
52 Week Price Performance
RN3
Industry Average

Nominating Committee* - arena pharmaceuticals inc (RN3)

Name (Connections)Board RelationshipsTitleKey Developments
Donald Belcher 18 RelationshipsIndependent Director and Chairman of Corporate Governance and Nominating CommitteeArena Pharmaceuticals, Inc. Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
07/5/12
Harry Hixson Jr., Ph.D. 32 RelationshipsIndependent Director, Chairman of Science Committee and Member of Corporate Governance & Nominating CommitteeArena Pharmaceuticals, Inc. Announces Executive Changes
06/20/12
Scott Bice 13 RelationshipsIndependent Director, Member of Audit Committee and Member of Corporate Governance & Nominating CommitteeRobert E. Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
08/12/11

Corporate Governance Committee* - arena pharmaceuticals inc (RN3)

Name (Connections)Board RelationshipsTitle
Donald Belcher 18 RelationshipsDirector, Chairman of Compensation Committee and Member of Science Committee
Scott Bice 13 RelationshipsLead Independent Director, Member of Compensation Committee, Member of Audit Committee and Member of Science Committee
Harry Hixson Jr., Ph.D. 32 RelationshipsIndependent Director and Member of Compensation Committee
RN3 and Competitor
Insiders vs. External
Board
22%
78%
Arena Pharmaceuticals, Inc.
22%
78%
Ariad Pharmaceuticals Inc.
9%
91%
Array BioPharma, Inc.
29%
71%
Rigel Pharmaceuticals, Inc.
14%
86%
Spectrum Pharmaceuticals, Inc.
16%
84%
Progenics Pharmaceuticals, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RN3:GR €2.80 EUR -0.175

RN3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $7.08 USD -0.011
Array BioPharma Inc $4.75 USD 0.00
Progenics Pharmaceuticals Inc $7.30 USD +0.062
Rigel Pharmaceuticals Inc $2.32 USD +0.03
Spectrum Pharmaceuticals Inc $7.03 USD +0.06
View Industry Companies
 

Industry Analysis

RN3

Industry Average

Valuation RN3 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 21.9x
Price/Book 9.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.